+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 85Years
All Genders
ID06095440

Retrospective Study of Treatment Outcomes for Hepatorenal Syndrome Patients at Methodist Dallas Medical Center

Led by Methodist Health System · Updated on 2026-05-01

500

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Hepatorenal syndrome HRS is a condition causing acute kidney injury in patients with liver disease, often due to circulatory changes from vasodilators like nitric oxide. It presents with elevated serum creatinine, benign urine sediment, and low urine sodium. The study evaluates outcomes in patients with HRS by comparing various treatment methods to better understand their effects and support treatment decisions. The research is a retrospective analysis of patients with HRS, focusing on treatments including vasoconstrictors, albumin, continuous renal replacement therapy CRRT, Molecular Adsorbent Recirculating System MARS, and transjugular intrahepatic portosystemic shunts TIPS. CRRT is considered especially for patients with severe electrolyte imbalances and can serve as a bridge to liver transplantation, although it carries risks such as low blood pressure and cardiac events. TIPS may improve kidney function by reducing portal pressure. Participants are patients over 18 hospitalized between April 2019 and April 2023 diagnosed with HRS. Researchers will review medical records to assess treatment outcomes, focusing on primary outcomes for HRS-AKI patients over four years and post-transplant mortality rates. The study involves no interventions or additional procedures beyond data analysis. The total participation involves reviewing historical data, with no direct patient involvement or follow-up.

CONDITIONS

Brief Title

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

Research Team

C

Colette Ngo Ndjom, MS

L

Loretta W Bedell, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here